Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.

Arthritis Res Ther · 2009 · PMC2714128 · PMID 19591653

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

Novel targets in the treatment of lupus patients: ongoing therapeutic trials Molecular targeted therapies have created an encouraging trend in the treatment of lupus.

also in 355 other papers

a positive trendno p-value reported

There was also a positive trend in SELENA – Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores and in complement levels in treated patients [ 3 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.